Endologix (NASDAQ:ELGX) was downgraded by stock analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a report issued on Friday, TheFlyOnTheWall.com reports. They currently have a $16.00 price target on the stock, down from their previous price target of $20.00. Oppenheimer’s price target would suggest a potential downside of 10.61% from the stock’s previous close. Endologix, Inc. (NASDAQ:ELGX) stock opened at $13.00 in last session, and closed at $13.50, while the day range of ELGX stock is $12.86-$13.95.The stock showed a negative weekly performance of -23.38%.
Gap Inc. (NYSE:GPS) updated its FY15 earnings guidance on Thursday. The company provided earnings per share guidance of $2.90-2.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.04,Analyst Ratings Network reports. The Gap Inc. (NYSE:GPS) stock opened at $43.93, in last session and closed at $43.75, by gained 0.16%. The 52 week range was $32.91-$46.56. Company’s market capitalization is $19.51 billion.
The Board of Directors of Sotheby’s (NYSE:BID) has declared a quarterly dividend of $0.10 for the first quarter of 2014. The first quarter dividend is payable on 17 March 2014 to shareholders of record as of 10 March 2014. Sothebys (NYSE:BID) stock loosed -6.67% and finished the last session at $47.01.The EPS of the stock remained 1.52. Company’s market capitalization is $3.22 billion.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its earnings data on Thursday. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.17) by $0.02,American Banking News.com reports. The company had revenue of $12.50 million for the quarter, compared to the consensus estimate of $21.80 million. During the same quarter in the prior year, the company posted ($0.04) earnings per share. The company’s quarterly revenue was down 42.7% on a year-over-year basis. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened the session at $15.40, and closed the session at $14.09.The 52 week range of the HALO stock remained $5.03-$18.18 and the day range was $13.50-$15.57.